Publication:
Effect of adding bemiparin and cefepime to routine treatment in cancer patients with SARS-CoV-2 infection.

Simple item page
dc.contributor.authorDoello, Kevin
dc.contributor.authorAmezcua, Víctor
dc.date.accessioned2023-02-09T11:39:56Z
dc.date.available2023-02-09T11:39:56Z
dc.date.issued2021-05-07
dc.identifier.doi10.1016/j.medcli.2021.03.010
dc.identifier.essn1578-8989
dc.identifier.pmcPMC8103150
dc.identifier.pmid34083071
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103150/pdf
dc.identifier.unpaywallURLhttps://doi.org/10.1016/j.medcli.2021.03.010
dc.identifier.urihttp://hdl.handle.net/10668/17949
dc.issue.number6
dc.journal.titleMedicina clinica
dc.journal.titleabbreviationMed Clin (Barc)
dc.language.isoen
dc.language.isoes
dc.organizationHospital Universitario Virgen de las Nieves
dc.page.number299-300
dc.pubmedtypeCase Reports
dc.rights.accessRightsopen access
dc.subject.meshCOVID-19
dc.subject.meshCefepime
dc.subject.meshHeparin, Low-Molecular-Weight
dc.subject.meshHumans
dc.subject.meshNeoplasms
dc.subject.meshSARS-CoV-2
dc.titleEffect of adding bemiparin and cefepime to routine treatment in cancer patients with SARS-CoV-2 infection.
dc.title.alternativeEfecto de la adición de bemiparina y cefepime al tratamiento habitual en el paciente oncológico con infección por SARS-CoV-2.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number157
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
PMC8103150.pdf
Size:
232.21 KB
Format:
Adobe Portable Document Format
Download

Collections

SAS - Hospital Universitario Virgen de las Nieves

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía